XML 16 R4.htm IDEA: XBRL DOCUMENT v3.25.3
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Millions
Sep. 30, 2025
Dec. 31, 2024
Assets    
Cash and cash equivalents $ 432 $ 549
Accounts receivable, net of allowance for credit losses of $26 and $29 as of September 30, 2025 and December 31, 2024, respectively 1,456 1,304
Inventories 186 188
Prepaid expenses and other current assets 333 351
Total current assets 2,407 2,392
Property, plant and equipment, net 2,145 2,113
Operating lease right-of-use assets 649 651
Goodwill 8,901 8,856
Intangible assets, net 1,662 1,763
Investments in equity method investees 137 123
Other assets 296 255
Total assets 16,197 16,153
Current liabilities:    
Accounts payable and accrued expenses 1,457 1,394
Current portion of long-term debt 504 602
Current portion of long-term operating lease liabilities 173 173
Total current liabilities 2,134 2,169
Long-term debt 5,171 5,615
Long-term operating lease liabilities 534 535
Other liabilities 982 938
Commitments and contingencies
Redeemable noncontrolling interest 81 83
Quest Diagnostics stockholders’ equity:    
Common stock, par value $0.01 per share; 600 shares authorized as of both September 30, 2025 and December 31, 2024; 162 shares issued as of both September 30, 2025 and December 31, 2024 2 2
Additional paid-in capital 2,355 2,361
Retained earnings 9,837 9,360
Accumulated other comprehensive loss (40) (88)
Treasury stock, at cost; 51 shares as of both September 30, 2025 and December 31, 2024 (4,896) (4,857)
Total Quest Diagnostics stockholders’ equity 7,258 6,778
Noncontrolling interests 37 35
Total stockholders’ equity 7,295 6,813
Total liabilities and stockholders’ equity $ 16,197 $ 16,153